These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3604153)

  • 1. Appraisal of the protein composition of prothrombin complex concentrates of different origins.
    Pejaudier L; Kichenin-Martin V; Boffa MC; Steinbuch M
    Vox Sang; 1987; 52(1-2):1-9. PubMed ID: 3604153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on prothrombin complex concentrates contact factors, complement components and proteinase inhibitors.
    Steinbuch M; Péjaudier L; Kichenin V; Boffa MC
    Thromb Haemost; 1984 Dec; 52(3):256-62. PubMed ID: 6531751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombogenicity of prothrombin complex concentrates].
    Dornheim G; Klöcking HP; Wulkow R; Storch H; Töpfer G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):571-9. PubMed ID: 1714862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Production and characterization of a new prothrombin complex concentrate].
    Dornheim G; Wegner H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):614-28. PubMed ID: 2414191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation proteins showing abnormal electrophoretic mobility in commercial concentrates of factor VIII and prothrombin complex.
    Vicente V; Alberca I; Calles I; Manso M; López Borrasca A
    Haemostasis; 1984; 14(6):453-9. PubMed ID: 6442908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T; Michalski C; Goudemand M; Huart JJ
    Vox Sang; 1989; 57(4):225-32. PubMed ID: 2617959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for systematic purification from bovine plasma of six vitamin K-dependent coagulation factors: prothrombin, factor X, factor IX, protein S, protein C, and protein Z.
    Hashimoto N; Morita T; Iwanaga S
    J Biochem; 1985 May; 97(5):1347-55. PubMed ID: 3161875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activated prothrombin complex preparations for the treatment of anticoagulant hemophilia. Preparation--method of operation--supply possibility].
    Wilms K; Sander W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):589-93. PubMed ID: 1714864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions to the optimal use of human blood. II. The large-scale preparation of prothrombin complex. A comparison between two methods using the anion exchangers DEAE-cellulose DE 52 and DEAE-sephadex A-50.
    Heystek J; Brummelhuis HG; Krunen HW
    Vox Sang; 1973; 25(2):113-23. PubMed ID: 4198999
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential interaction of clotting factors II, VII, IX and X with sephadex and dextran blue.
    Swart AC; Kop-Klaassen BH; Hemker HC
    Haemostasis; 1972-1973; 1(5):237-52. PubMed ID: 4670119
    [No Abstract]   [Full Text] [Related]  

  • 12. [Technology optimization and properties study of factor IV complex concentrates].
    Zeng R; Yu R; Li X; Wu Y; Qi H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):142-4. PubMed ID: 15600207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography.
    Ahmad SS; Rawala-Sheikh R; Thompson AR; Walsh PN
    Thromb Res; 1989 Jul; 55(1):121-33. PubMed ID: 2781515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The isolation of prothrombin, Factor IX and Factor X from human Factor IX concentrates.
    Modi GJ; Blajchman MA; Ofosu FA
    Thromb Res; 1984 Dec; 36(6):537-47. PubMed ID: 6084874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of factor IX concentrates for clinical use by ion-exchange chromatography and ammonium sulphate precipitation.
    Stampe D; Wieland B; Köhle A
    J Chromatogr; 1986 Aug; 363(1):101-3. PubMed ID: 3760052
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of expanded bed adsorption chromatography for extraction of prothrombin complex from Cohn Supernatant I.
    McCann KB; Gomme PT; Wu J; Bertolini J
    Biologicals; 2008 Jul; 36(4):227-33. PubMed ID: 18329287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of plasma protein.
    Mannhalter C
    Haemostasis; 1988; 18 Suppl 1():115-9. PubMed ID: 3280421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of various heat-treated prothrombin complex concentrates (PCC).
    Yoshioka A; Nakagawa O; Uehara Y; Sakai T; Sugimoto M; Takamiya O; Tanaka I; Fukui H
    Thromb Res; 1987 Aug; 47(4):449-58. PubMed ID: 2958958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct capture of plasma factor VIII:C by ion exchange chromatography.
    Teh LC; Froger M
    Vox Sang; 1994; 67(1):8-13. PubMed ID: 7975461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new subfraction of routine fractionation.
    Steinbuch M; Pejaudier L; Tavernier D; Lejars A
    Rev Fr Transfus Immunohematol; 1980; 23(3):341-55. PubMed ID: 7406998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.